The global oncology information systems (OIS) market is witnessing strong growth as healthcare providers increasingly adopt integrated digital platforms to manage complex cancer care workflows. According to Straits Research, the oncology information systems market was valued at USD 3.16 billion in 2025 and is expected to grow from USD 3.41 billion in 2026 to USD 6.39 billion by 2034, expanding at a CAGR of 8.16% during the forecast period (2026–2034).
Healthcare systems worldwide are shifting toward data-driven oncology ecosystems that integrate patient records, imaging, treatment planning, and clinical analytics into a unified digital platform. This transformation is driven by the rise of precision medicine, genomic-based therapies, and value-based care models, which require accurate data management and real-time clinical decision support. Oncology information systems are becoming essential for improving treatment outcomes, supporting multidisciplinary care teams, and enabling long-term patient monitoring.
Get your Sample Report to Boost Your Industry Knowledge for Valuable Insights! https://straitsresearch.com/report/oncology-information-system-market/request-sample
As cancer treatment grows increasingly complex, healthcare organizations are prioritizing oncology platforms that ensure interoperability, regulatory compliance, and seamless integration with electronic health records (EHRs), imaging systems, and laboratory databases. Vendors are responding with AI-enabled analytics, modular architectures, and cloud-based deployment models that help institutions manage growing oncology data volumes and support advanced clinical workflows.
Market Drivers
Rising Demand for Value-Based Oncology Care and Structured Data Systems
One of the primary drivers of the oncology information systems market is the growing adoption of value-based healthcare models, which emphasize patient outcomes and cost efficiency rather than service volume. Healthcare providers require advanced systems capable of capturing clinical and financial data to measure treatment effectiveness, improve care pathways, and support reimbursement reporting.
The expansion of oncology data ecosystems also fuels market growth. National cancer registries, population-level cancer research initiatives, and clinical trial networks require standardized digital platforms capable of capturing longitudinal patient data across treatment stages. Structured oncology information systems allow healthcare institutions to track treatment outcomes, improve care quality, and participate in research collaborations that support advancements in cancer therapy.
Market Challenges / Restraining Factors
Complex Workflow Customization and Data Privacy Regulations
Despite strong demand, implementing oncology information systems remains challenging due to the complexity of oncology workflows, which differ significantly across healthcare institutions and cancer treatment protocols. Treatment pathways vary based on cancer type, stage, and institutional practices, requiring extensive system customization before full-scale deployment.
Another significant barrier involves strict healthcare data protection regulations. Policies governing patient data privacy and cross-border data sharing restrict the seamless exchange of oncology information across global healthcare networks. Regulatory frameworks such as healthcare data protection laws require vendors to develop region-specific compliance strategies, secure data hosting infrastructure, and advanced encryption standards. These requirements increase development costs and limit the scalability of centralized oncology platforms.
Market Opportunities
Integration of Genomic Data and Expansion of Ambulatory Cancer Care
The integration of genomic sequencing data into oncology information systems presents one of the most significant growth opportunities in the market. Precision oncology relies heavily on genomic insights to determine personalized treatment strategies. As large-scale genomic research initiatives generate vast datasets, healthcare providers increasingly need platforms capable of integrating genomic data with clinical records and treatment pathways.
Another major opportunity lies in the rapid expansion of ambulatory cancer care centers and specialized oncology clinics. These facilities require scalable, cost-effective digital solutions that can be deployed quickly without complex IT infrastructure. Cloud-based oncology information systems and subscription-based software models are gaining traction in decentralized care environments, expanding the addressable market beyond large hospitals.
Get Full Report with TOC: https://straitsresearch.com/report/oncology-information-system-market
Regional Insights
North America Leads the Global Market
North America accounted for the largest market share of 40.01% in 2025, supported by strong regulatory frameworks promoting healthcare data interoperability and value-based care models. The region’s advanced healthcare infrastructure and robust oncology research ecosystem accelerate the adoption of sophisticated oncology information platforms.
The United States remains the largest contributor to regional growth due to extensive cancer data networks and research collaborations. The country benefits from large-scale oncology datasets and strong partnerships between healthcare institutions and technology providers, which facilitate the integration of clinical data with advanced analytics platforms.
Canada is also witnessing steady growth due to provincial healthcare IT initiatives and the expansion of structured cancer registries that require standardized oncology data reporting.
Asia-Pacific Expected to Register the Fastest Growth
The Asia-Pacific region is projected to be the fastest-growing market during the forecast period, registering a CAGR of 10.16%. Rapid digital transformation in healthcare, increasing cancer incidence rates, and national cancer control programs are driving demand for oncology information systems across the region.
Countries such as India, China, and Japan are investing heavily in digital health infrastructure and smart hospital initiatives. These programs aim to integrate clinical imaging, laboratory data, and oncology treatment planning into centralized digital platforms. The rise of national cancer registries and AI-driven diagnostic tools further accelerates market growth across Asia-Pacific.
Competitive Landscape
The oncology information systems market features a moderately fragmented competitive landscape, with global healthcare IT providers competing alongside specialized oncology technology companies. Market leaders focus on expanding integrated enterprise platforms capable of supporting imaging, treatment planning, patient management, and clinical analytics within a single architecture.
Key companies operating in the global oncology information systems market include:
Bogardus Medical Systems Inc. Charm Health Leo Cancer Care Royal Philips Accuray Incorporated Siemens Healthcare Insilico Medicine Elekta AB CureMD Corporation Cerner Corporation Flatiron Health Inc. Epic Systems Corporation McKesson Corporation Bizmatics Inc. RaySearch Laboratories AB Koninklijke Philips N.V. Cordata Healthcare Innovations LLC Varian Medical Systems Inc. IMPAC Medical Systems Inc.
These companies are investing in AI-powered decision support, cloud-based oncology platforms, and real-world evidence analytics to strengthen their competitive position and support precision cancer care initiatives.
Market Segmentation
By Product & Service
The solutions segment is expected to register strong growth due to rising demand for integrated oncology platforms that connect patient information systems with treatment planning tools. Healthcare providers are increasingly adopting unified digital systems that enhance clinical decision-making and workflow efficiency.
Professional services—including consulting, implementation, system integration, and training—are also experiencing strong demand as healthcare institutions require specialized expertise to deploy complex oncology IT infrastructure.
By Application
The medical oncology segment accounted for the largest market share of 63.41% in 2025, driven by the high patient volume associated with chemotherapy and systemic cancer treatments. Oncology information systems help manage treatment regimens, patient histories, and medication safety monitoring.
The surgical oncology segment is expected to witness strong growth as healthcare providers increasingly adopt digital solutions that support preoperative planning, imaging analysis, and postoperative patient monitoring.
By End Use
Hospitals and diagnostic imaging centers dominated the end-use segment with a 48.01% market share in 2025, as they serve as primary hubs for cancer diagnosis and treatment. These institutions require integrated oncology systems to manage large patient volumes and complex treatment workflows.
Specialized cancer care centers and ablation care facilities are also emerging as key adopters of oncology information systems due to the growing demand for targeted therapies and outpatient cancer treatments.
Recent Developments
Industry innovation continues to accelerate the evolution of oncology information systems.
In March 2026, Insilico Medicine entered a USD 888 million partnership with Servier to accelerate AI-driven oncology drug discovery, highlighting the growing integration of artificial intelligence in cancer research and treatment planning.
In February 2026, Royal Philips announced that its PreciseOnco research consortium secured €14.9 million in funding under the EU Innovative Health Initiative to advance precision oncology treatment technologies.
Earlier, in October 2025, Leo Cancer Care introduced an upright photon therapy system designed to enhance patient comfort and improve radiotherapy workflow efficiency. The system integrates advanced software platforms that support connected oncology treatment planning and patient management.
With cancer incidence rising worldwide and healthcare systems shifting toward precision medicine and value-based care, oncology information systems are becoming a critical digital infrastructure for modern cancer treatment. Continuous technological advancements in AI analytics, genomic data integration, and cloud-based healthcare platforms are expected to drive sustained growth in the global oncology information systems market through 2034.
